| HOME >> BIOLOGY >> TECHNOLOGY |
(Unaudited)Three Months EndedThree Months EndedJune 30, 2011June 30, 2010Non—GAAPAdjustmentsGAAPNon—GAAPAdjustmentsGAAPRevenues:Product sales
$132,921
$ —
$132,921$132,734
$ —
$132,734Collaborative research revenue
1,617
—
1,6174,141
—
4,141Royalty and license revenue
1,360
—
1,3601,774
—
1,774Total revenues
135,898
—
135,898138,649
—
138,649Operating expenses:Cost of product sales (excluding acquisition-related intangible amortization)
39,329
102
39,43144,221
90
44,311Acquisition-related intangible amortization
—
2,729
2,729—
2,199
2,199Research and development
27,696
17
27,71327,104
—
27,104Marketing and sales
17,504
6
17,51015,824
—
15,824General and administrative
17,308
1,395
18,70314,349
669
15,018Total operating expenses
101,837
4,249
106,086101,498
2,958
104,456Income from operations
34,061
(4,249)
29,81237,151
(2,958)
34,193Other income (expense):Investment and interest income
2,937
—
2,9373,269
—
3,269Interest expense
(497)
—
(497)(549)
—
(549)Gain on contingent consideration
—
—
——
4,337
4,337Other income (expense), net
1,315
—
1,315(190)
—
(190)Total other income, net
3,755
—
3,7552,530
4,337
6,867Income before income tax
37,816
(4,249)
33,56739,681
1,379
41,060Income tax expense
| SOURCE Gen-Probe Incorporated Copyright©2010 PR Newswire. All rights reserved |